Fortress Biotech (FBIO) Share-based Compensation (2010 - 2026)
Fortress Biotech (FBIO) reported Share-based Compensation of $2.88 million for Q2 2026, down 82.9% from $16.79 million a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Fortress Biotech's Share-based Compensation came in at $25.33 million, down 44.8% year-over-year; for FY2025, it was $28.74 million, down 11.9% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 16.4% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $32.62 million in FY2024 (+91.5%), $17.03 million in FY2023 (-25.9%), $22.99 million in FY2022 (+18.0%) and $19.49 million in FY2021 (+44.9%).
- Five-year quarterly Share-based Compensation spans a low of $2.46 million in Q4 2025 and a high of $16.79 million in Q2 2025.
- Year over year, Share-based Compensation gained in four of the last seven quarters, with growth averaging 62.0%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2024 (growth of 337.1%); the low point was Q4 2025 (a decline of 84.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Fortress Biotech | 62.47 Mn | -555.55 Mn | 12.58 Mn | 2.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 16.79 Mn |
| Mar 31, 2025 | 6.29 Mn |
| Dec 31, 2024 | 16.19 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 5.08 Mn |
| Mar 31, 2022 | 5.56 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Sep 30, 2021 | 4.33 Mn |
| Jun 30, 2021 | 4.35 Mn |
API Access
Fortress Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();